AI assistant
INCYTE CORP — Director's Dealing 2024
Jul 17, 2024
30371_dirs_2024-07-17_873b5cc9-93ca-4a17-bfa7-3c19d9381668.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2024-07-15
Reporting Person: Denton Sheila A. (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-15 | Common Stock | A | 5955 | — | Acquired | 32479 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-15 | Employee Stock Option (right to buy) | $64.25 | A | 13323 | Acquired | 2034-07-14 | Common Stock (13323) | Direct |
Footnotes
F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2: Including the July 15, 2024 grant, this includes an aggregate of 32,479 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
F3: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.